Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy.

Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH, AVOID Study Investigators
Diabetes Care. 2010 33 (11): 2304-9

PMID: 20693353 · PMCID: PMC2963484 · DOI:10.2337/dc10-0833

MeSH Terms (15)

Aged Albuminuria Amides Antihypertensive Agents Creatinine Diabetes Mellitus, Type 2 Diabetic Nephropathies Female Fumarates Humans Kidney Diseases Kidney Function Tests Losartan Male Middle Aged

Connections (1)

This publication is referenced by other Labnodes entities: